RE:RE:RE:RE:Expected a bit more but...Well, while replacing COVID income will be a task in itself, I think DM has positioned itself nicely throughout 2022 (i.e. Nexalogy $40M defense contract, continued repeat commercial contracts and new eHealth and DM EVS verticals devleopment) and that 2023 will be the year where it truly gains AI-driven tractions, not-the-least with newfound AnalyticsGPT.
As such I'm happy for DM to continue with its stream of NRs, covering all verticals, and am confident quarterly financials will demonstrate growing overall income QoQ.
In the meantime, I'm happy COVID-driven income has secured DM's warchest, making it sail the inflation and increased interest rates challenges other businesses are having to face (i.e. through issuing high interest debentures, taking various types of loans, diluting etc).